Drug Abuse Warning Network US (DAWN-NS-1997)
Resources
1 resource available
-
https://datafiles.samhsa.gov/study/drug-abuse-warning-network-us-dawn-ns-1997-nid13592
TEXT/HTML
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[
"009:30"
]
|
| contactPoint |
{
"fn": "Brooklyn Lupari, SAMHSA/CBHSQ c/o SAMHDA Support",
"@type": "vcard:Contact",
"hasEmail": "mailto:samhda-support@samhsa.hhs.gov"
}
|
| description | <p>The Drug Abuse Warning Network (DAWN) survey is designed to<br /> capture data on emergency department (ED) episodes that are induced by<br /> or related to the use of an illicit, prescription, or over-the-counter<br /> drug. For purposes of this collection, a drug "episode" is an ED visit<br /> that was induced by or related to the use of an illegal drug or the<br /> nonmedical use of a legal drug for patients aged six years and<br /> older. A drug "mention" refers to a substance that was mentioned<br /> during a drug-related ED episode. Because up to four drugs can be<br /> reported for each drug abuse episode, there are more mentions than<br /> episodes in the data. Individual persons may also be included more<br /> than once in the data. Within each facility participating in DAWN, a<br /> designated reporter, usually a member of the emergency department or<br /> medical records staff, was responsible for identifying drug-related<br /> episodes and recording and submitting data on each case. An episode<br /> report was submitted for each patient visiting a DAWN emergency<br /> department whose presenting problem(s) was/were related to their own<br /> drug use. DAWN produces estimates of drug-related emergency department<br /> visits for 50 specific drugs, drug categories, or combinations of<br /> drugs, including the following: acetaminophen, alcohol in combination<br /> with other drugs, alprazolam, amitriptyline, amphetamines, aspirin,<br /> cocaine, codeine, diazepam, diphenhydramine, fluoxetine,<br /> heroin/morphine, inhalants/solvents/aerosols, LSD, lorazepam,<br /> marijuana/hashish, methadone, methamphetamine, and PCP/PCP in<br /> combination with other drugs. The use of alcohol alone is not<br /> reported. The route of administration and form of drug used (e.g.,<br /> powder, tablet, liquid) are included for each drug. Data collected for<br /> DAWN also include drug use motive and total drug mentions in the<br /> episode, as well as race, age, patient disposition, reason for ED<br /> visit, and day of the week, quarter, and year of episode.This study has 1 Data Set.</p> |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "https://datafiles.samhsa.gov/study/drug-abuse-warning-network-us-dawn-ns-1997-nid13592",
"mediaType": "text/html",
"description": "Drug Abuse Warning Network US (DAWN-NS-1997)
",
"downloadURL": "https://datafiles.samhsa.gov/study/drug-abuse-warning-network-us-dawn-ns-1997-nid13592"
}
]
|
| identifier | https://datafiles.samhsa.gov/study/drug-abuse-warning-network-us-dawn-ns-1997-nid13592 |
| issued | 2016-05-23 |
| keyword |
[
"demographic characteristics",
"drug abuse",
"drug dependence",
"drug overdose",
"drug use",
"emergencies",
"emergency services",
"health behavior",
"hospitalization",
"substance abuse"
]
|
| landingPage | https://healthdata.gov/dataset/drug-abuse-warning-network-us-dawn-ns-1997 |
| modified | 2023-07-25 |
| programCode |
[
"009:030"
]
|
| publisher |
{
"name": "Substance Abuse & Mental Health Services Administration",
"@type": "org:Organization"
}
|
| title | Drug Abuse Warning Network US (DAWN-NS-1997) |